Tahir Amin

Co-Founder and Chief Executive Officer at I-MAK, Co-author of Pharma Monopoly (2026).

Tahir Amin

Co-Founder and Chief Executive Officer at I-MAK, Co-author of Pharma Monopoly (2026).

At-a-Glance

Biography

Tahir Amin, LL.B., Dip. LP. is the co-author of Pharma Monopoly: The Battle for the Future of Medicines and a founder and CEO of the Initiative for Medicines, Access & Knowledge (I-MAK).

With over 30 years of experience in intellectual property (IP) law, including practice at two leading UK IP law firms and roles as IP Counsel for multinational corporations, Tahir has built a career at the intersection of law, public health, and systemic change.